{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:18:03Z","timestamp":1778617083990,"version":"3.51.4"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Swedish Breast Cancer Association","award":["2018-0008"],"award-info":[{"award-number":["2018-0008"]}]},{"name":"Region V\u00e4sterbotten","award":["RV1014216"],"award-info":[{"award-number":["RV1014216"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer (Bc) is the leading cause of cancer-related death in women. In many patients, BC liver metastases (BCLM) are associated with short survival. The aims of this study were to investigate the risk of and time to BCLM in each BC surrogate subtype, and to determine the incidence of BCLM in a population-based setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Swedish national breast cancer registry identified patients with Bc in a regional cohort from 2009 to 2018. The cohort was followed until January 2023. Cox regression analysis was used to determine the risk of BCLM for each subtype. Kaplan\u2013Meier estimates determined the probability of BCLM for each subtype over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In all, 7292 patients with Bc were included in the study. Distant metastases developed in 755 patients (10.4%); of these, 345 (45.7%) developed BCLM. The BCLM incidence rate was 8 per 1000 person-years. Only 13 patients had oligometastases isolated to the liver. Triple-negative, non-luminal human epidermal growth factor receptor 2 (HER2)-positive and luminal B cancers had the highest risk of BCLM. T category, nodal status, and Nottingham histological grade III were also strongly associated with BCLM. The median time from Bc diagnosis to BCLM was 36 months. Patients with HER2-positive BC subtypes developed BCLM early, at a median of only 9 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Bc subtype is correlated to the risk and timing of BCLM development. BCLM are common in advanced Bc, but isolated oligometastases are rare.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjsopen\/zrag036","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T12:40:40Z","timestamp":1773751240000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of breast cancer characteristics on the development and time to liver metastases: population-based study"],"prefix":"10.1093","volume":"10","author":[{"given":"Marcus","family":"Sund\u00e9n","sequence":"first","affiliation":[{"name":"Department of Diagnostics and Intervention, Surgery, Ume\u00e5 University , Ume\u00e5 ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elin","family":"Lindqvist","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Intervention, Surgery, Ume\u00e5 University , Ume\u00e5 ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Wahlqvist","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Intervention, Surgery, Ume\u00e5 University , Ume\u00e5 ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Hansson","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Intervention, Surgery, Ume\u00e5 University , Ume\u00e5 ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0571-7265","authenticated-orcid":false,"given":"Charlotta","family":"Wadsten","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Intervention, Surgery, Ume\u00e5 University , Ume\u00e5 ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Andersson","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Intervention, Oncology, Ume\u00e5 University , Ume\u00e5 ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7516-9543","authenticated-orcid":false,"given":"Malin","family":"Sund","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Intervention, Surgery, Ume\u00e5 University , Ume\u00e5 ,","place":["Sweden"]},{"name":"Department of Surgery, University of Helsinki and Helsinki University Hospital , Helsinki ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1732-168X","authenticated-orcid":false,"given":"Oskar","family":"Hemmingsson","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Intervention, Surgery, Ume\u00e5 University , Ume\u00e5 ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"2026051215372260100_zrag036-B1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41416-022-01845-z","article-title":"Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study","volume":"127","author":"Valachis","year":"2022","journal-title":"Br J Cancer"},{"key":"2026051215372260100_zrag036-B2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1308\/rcsann.2021.0308","article-title":"Breast cancer liver metastases: systematic review and time to event meta-analysis with comparison between available treatments","volume":"105","author":"Rangarajan","year":"2023","journal-title":"Ann R Coll Surg Engl"},{"key":"2026051215372260100_zrag036-B3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1006308619659","article-title":"Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis","volume":"59","author":"Solomayer","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"2026051215372260100_zrag036-B4","doi-asserted-by":"crossref","first-page":"45411","DOI":"10.1038\/srep45411","article-title":"Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study","volume":"7","author":"Gong","year":"2017","journal-title":"Sci Rep"},{"key":"2026051215372260100_zrag036-B5","doi-asserted-by":"crossref","first-page":"27990","DOI":"10.18632\/oncotarget.15856","article-title":"Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"2026051215372260100_zrag036-B6","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.3390\/jcm10245873","article-title":"Molecular subtypes, metastatic pattern and patient age in breast cancer: an analysis of Italian network of cancer registries (AIRTUM) data","volume":"10","author":"Tagliabue","year":"2021","journal-title":"J Clin Med"},{"key":"2026051215372260100_zrag036-B7","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.ejca.2014.04.002","article-title":"Age at diagnosis and distant metastasis in breast cancer\u2014a surprising inverse relationship","volume":"50","author":"Purushotham","year":"2014","journal-title":"Eur J Cancer"},{"key":"2026051215372260100_zrag036-B8","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.2147\/CMAR.S176763","article-title":"Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study","volume":"10","author":"Xiao","year":"2018","journal-title":"Cancer Manag Res"},{"key":"2026051215372260100_zrag036-B9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.breast.2016.07.016","article-title":"The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival","volume":"29","author":"Vasconcelos","year":"2016","journal-title":"Breast"},{"key":"2026051215372260100_zrag036-B10","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO clinical practice guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann Oncol"},{"key":"2026051215372260100_zrag036-B11","doi-asserted-by":"crossref","first-page":"103839","DOI":"10.1016\/j.breast.2024.103839","article-title":"Treatment of oligometastatic breast cancer: the role of patient selection","volume":"79","author":"Colciago","year":"2025","journal-title":"Breast"},{"key":"2026051215372260100_zrag036-B12","doi-asserted-by":"crossref","first-page":"e2300285","DOI":"10.1200\/GO.23.00285","article-title":"Systemic treatment of patients with metastatic breast cancer: ASCO resource-stratified guideline","volume":"10","author":"Al Sukhun","year":"2024","journal-title":"JCO Glob Oncol"},{"key":"2026051215372260100_zrag036-B13","author":"Regionala cancercentrum (RCC)"},{"key":"2026051215372260100_zrag036-B14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ejso.2020.02.008","article-title":"Surgical treatment of breast cancer liver metastases\u2014a nationwide registry-based case control study","volume":"46","author":"Sund\u00e9n","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"2026051215372260100_zrag036-B15","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.ejso.2020.03.214","article-title":"Hepatic resection for breast cancer liver metastases: impact of surrogate subtypes","volume":"46","author":"Chun","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"2026051215372260100_zrag036-B16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/livers5030032","article-title":"Robotic liver resection for breast cancer metastasis: a multicenter case series and literature review","volume":"5","author":"Caringi","year":"2025","journal-title":"Livers"},{"key":"2026051215372260100_zrag036-B17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/SLA.0000000000001371","article-title":"Hepatic resection or ablation for isolated breast cancer liver metastasis: a case-control study with comparison to medically treated patients","volume":"264","author":"Sadot","year":"2016","journal-title":"Ann Surg"}],"container-title":["BJS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjsopen\/article-pdf\/10\/3\/zrag036\/68274275\/zrag036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjsopen\/article-pdf\/10\/3\/zrag036\/68274275\/zrag036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:37:31Z","timestamp":1778614651000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjsopen\/article\/doi\/10.1093\/bjsopen\/zrag036\/8676604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5,12]]}},"URL":"https:\/\/doi.org\/10.1093\/bjsopen\/zrag036","relation":{},"ISSN":["2474-9842"],"issn-type":[{"value":"2474-9842","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,5,12]]},"article-number":"zrag036"}}